Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study Finds Majority of Women Willing to Accept Cervical Cancer Vaccine for Self and Children

23.03.2005


In a study of 200 women, a group of physicians has found that a vast majority of women would be willing to take a cervical cancer vaccine themselves and would allow it to be administered to their children. The findings, which were presented at the Society of Gynecologic Oncologist’s (SGO) Annual Meeting on Women’s Cancer in Miami, describes women’s attitudes toward a potential cervical cancer vaccine, focusing on their willingness to accept it for themselves, and their daughters and sons. It is the first study to examine women’s perceptions of a vaccine for both girls and boys.

Specifically, the study included 200 surveys conducted between February and December 2004 at gynecology and adolescent medical clinics at The University of Texas, Galveston. Women with children between the ages of eight and 14 were asked to take the survey, which was available in both English and Spanish. Women also received an education statement that explained that the human papillomavirus (HPV) is a virus that can cause cervical cancer. The statement also explained that scientific studies showed that a cervical cancer vaccine may be available within the next couple of years, and that this vaccine would work by preventing HPV, which is transmitted through sexual contact.

Results showed that 76 percent of women surveyed would be willing to accept a cervical cancer vaccine for themselves. Sixty-seven percent of women who had a daughter would consent to have their child vaccinated, compared to 64 percent of women with a son. Stated reasons for women not accepting the vaccine included unknown side effects and not currently being sexually active. Reasons for refusing consent for their children to be vaccinated included: unknown side effects, the belief that minors are not sexually active, and for boys, the belief that there was no direct benefit to them.



As the vaccine would need to be administrated prior to first sexual activity, 23 percent of women who were not willing to vaccinate their children stated that they did not want their child to participate in sex education. In the survey, it was found that 11 years of age was the mean age noted by participants as an appropriate time to provide children with sex education. "This study shows that education will be key to acceptance of the vaccine,” said Diane C. Bodurka, MD, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center. “Given that the vaccine may be available in the next five to 10 years, it is critical that we begin educating parents, especially mothers, now about how the vaccine will be crucial to the prevention of cervical cancer. It is also important for everyone to understand that a vaccine will be aimed at both boys and girls, and how this will help prevent the disease worldwide.”

Factors influencing a woman’s acceptance of the vaccine included their acceptance of all previously recommended vaccines for a child and acceptance of the vaccine for themselves. Neither demographic considerations, such as income, religion, race and education, nor a history of an abnormal Pap test were found to alter the patterns of potential acceptance of the vaccine.

Sarah Handza | EurekAlert!
Further information:
http://www.sgo.org

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>